Switch to
More onapp

How to use scorecard? Learn more

Supriya Lifescience Ltd

SUPRIYA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹3,237 cr, stock is ranked 833
High RiskStock is 4.31x as volatile as Nifty
422.1019.80 (+4.92%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹3,237 cr, stock is ranked 833
High RiskStock is 4.31x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
26.89
PB RatioPB Ratio
4.63
Dividend YieldDiv. Yield
0.15%
Sector PESector PE
51.72
Sector PBSector PB
5.89
Sector Div YldSctr Div Yld
0.55%

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Supriya Lifescience is a manufacturer of pharmaceutical preparation.

Investor PresentationView older 

Aug 3, 2023

PDF
View Older Presentations

Financial TrendFinancial statements 

2020202120222023322.71396.22537.63470.4373.36123.60151.8189.86
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Trading Window-XBRL 
Announced OnMar 28, 2024

Supriya Lifescience Limited has informed the Exchange about Closure of Trading Window | Download

Supriya Lifescience Limited has informed the Exchange about Closure of Trading Window | Download

Reply to Clarification- Financial results 
Announced OnMar 15, 2024

The Exchange had sought clarification from Supriya Lifescience Limited for the quarter ended 31-Dec-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Segment details not submitted The response of the Company is enclosed. | Download

The Exchange had sought clarification from Supriya Lifescience Limited for the quarter ended 31-Dec-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Segment details not submitted The response of the Company is enclosed. | Download

Cash Dividend 
Ex. DateSep 15, 2023

Final • Div/Share: ₹ 0.6

See all events